An impaired sulfoxidation pathway has been implicated in the pathogenesis of chlorpromazineinduced hepatotoxicity. Since some patients with chronic chlorpromazine-induced cholestasis may have features of primary biliary cirrhosis, we studied the ability to sulfoxidate the amino acid analogue 5'-carb
Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis
β Scribed by Yasuhiko Kimura; Carlo Selmi; Patrick S. C. Leung; Tin K. Mao; Joseph Schauer; Mitchell Watnik; Shigeki Kuriyama; Mikio Nishioka; Aftab A. Ansari; Ross L. Coppel; Pietro Invernizzi; Mauro Podda; M. Eric Gershwin
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 151 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Epidemiological data suggest that environmental factors may trigger autoimmunity in genetically susceptible individuals. In primary biliary cirrhosis (PBC), it has been postulated that halogenated xenobiotics can modify self-molecules, facilitating the breakdown of tolerance to mitochondrial antigens. The transport and metabolism of xenobiotics is highly dependent on key genetic polymorphisms that alter enzymatic phenotype. We analyzed genomic DNA from 169 patients with PBC and 225 geographically and sex-matched healthy subjects for polymorphisms of genes coding for cytochromes P450 (CYPs) 2D6 (CYP2D6*4, CYP2D6*3, CYP2D6*5, and CYP2D6*6) and 2E1 (cl/c2), multidrug resistance 1 (MDR1 C3435T) P-glycoprotein, and pregnane X receptor (PXR C-25385T, C8055T, and A7635G). We compared the genotype frequencies in patients and controls and also correlated polymorphisms with PBC severity. The distributions of the studied genotypes did not significantly differ between patients and controls. However, when clinical characteristics of patients with PBC were compared according to genotype, the CYP2E1 c2 allele was associated with signs of more severe disease. In conclusion, genetic polymorphisms of CYP 2D6 and 2E1, PXR, and MDR1 do not appear to play a role in the onset of PBC.
π SIMILAR VOLUMES
Symptomatology and objective findings of Sjogren's syndrome were evaluated in 38 consecutive patients with primary biliary cirrhosis. Symptoms of Sjogren's syndrome were present in 18 (47.4%) patients, but were severe enough to warrant therapy in only four (10.6%). Nineteen patients consented to eva
The impact of primary biliary cirrhosis (PBC) on health-related quality of life (HRQOL) is poorly documented. We assessed quality of life in a group of 276 unselected patients with PBC using the Nottingham Health Profile (NHP). This is a generic scale that assesses six major areas commonly associate
Primary biliary cirrhosis (PBC) is generally a slowly progressive disease that may lead to cirrhosis and liver failure. However, patients with PBC often suffer from a variety of symptoms long before the development of cirrhosis that include issues of daily living that have an impact on their work en